+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Search for: NeuroDiscovery Ltd-Therapeutic Competitors Report

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 67 Pages
  • Global
From
Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 295 Pages
  • Global
From
Sickle Cell Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Sickle Cell Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 277 Pages
  • Global
From
Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 643 Pages
  • Global
From
Glaucoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Glaucoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 347 Pages
  • Global
From
Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 589 Pages
  • Global
From
Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 210 Pages
  • Global
From
Down Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Down Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 74 Pages
  • Global
From
Osteoarthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Osteoarthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 413 Pages
  • Global
From
Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) - Drugs in Development, 2021 - Product Thumbnail Image

Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Aptamers Global Market Report 2024 - Product Thumbnail Image

Aptamers Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Precision Medicine Market Report 2023-2033 - Product Thumbnail Image

Precision Medicine Market Report 2023-2033

  • Report
  • June 2023
  • 347 Pages
  • Global
From
Traumatic Brain Injury (Central Nervous System) - Drugs in Development, 2021 - Product Thumbnail Image

Traumatic Brain Injury (Central Nervous System) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Neurology Devices Global Market Report 2024 - Product Thumbnail Image

Neurology Devices Global Market Report 2024

  • Report
  • February 2024
  • 400 Pages
  • Global
From
RAF Proto Oncogene Serine, Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

RAF Proto Oncogene Serine, Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 117 Pages
  • Global
From
Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 83 Pages
  • Global
From
Depression - Pipeline Review, H2 2020 - Product Thumbnail Image

Depression - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 737 Pages
  • Global
From
Down Syndrome - Pipeline Review, H2 2020 - Product Thumbnail Image

Down Syndrome - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 84 Pages
  • Global
From
Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2020 - Product Thumbnail Image

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 195 Pages
  • Global
From
Central Nervous System Biomarkers Global Market Report 2024 - Product Thumbnail Image

Central Nervous System Biomarkers Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Loading Indicator